home / stock / zntl / zntl message board
Subject | By | Source | When |
---|---|---|---|
We managed to get a new 26 week | ANTADOG | investorshub | 07/04/2020 6:31:24 PM |
Added some 46's , nice chart reset, ANT | ANTADOG | investorshub | 06/30/2020 8:24:03 PM |
55.12~~ looks like this puppy is on it's | ANTADOG | investorshub | 06/25/2020 2:26:00 PM |
NEW YORK and SAN DIEGO, June 15, 2020 | ANTADOG | investorshub | 06/19/2020 9:34:03 PM |
NEW YORK and SAN DIEGO, May 28, 2020 | ANTADOG | investorshub | 05/30/2020 9:44:18 AM |
New 52 week high at 52.09, i luv | ANTADOG | investorshub | 05/29/2020 8:04:34 PM |
Cash Position: As of March 31, 2020, Zentalis | ANTADOG | investorshub | 05/19/2020 5:00:51 PM |
Chart is pretty fresh here, anyway, i see | ANTADOG | investorshub | 05/19/2020 3:09:18 PM |
promisin' co, interestin' pipeline, touched new 52 week | ANTADOG | investorshub | 05/15/2020 5:37:50 PM |
$ZNTL opens @ 25.20 > | crudeoil24 | investorshub | 04/03/2020 4:27:21 PM |
Zentalis Pharma Upsized IPO Prices at High End | crudeoil24 | investorshub | 04/03/2020 2:56:56 PM |
Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company | crudeoil24 | investorshub | 04/03/2020 2:56:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Zentalis Pharmaceuticals Inc. Company Name:
ZNTL Stock Symbol:
NASDAQ Market:
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) is one of today's top gainers. The company's shares have moved 30.16% on the day to $5.39. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatme...
2024-06-20 08:30:04 ET UBS analyst issues NEUTRAL recommendation for ZNTL on June 20, 2024 06:35AM ET. ZNTL was trading at $4.14 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 4 - Hold recommend...
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financia...